COMP <GO>
BLLN vs UNH // PIOTROSKI F-SCORE QUALITY
BillionToOne Inc. (NASDAQ) VS. UnitedHealth Group Incorporated (NYSE) • 15-METRIC TALLY: BLLN 6
— UNH 9
▲ PIOTROSKI F-SCORE QUALITY LEADER: BLLN
LAST: $113.32 (-1.32%) • MKT CAP: $5.42B
piotroski-score
9/9
LAST: $406.97 (-0.96%) • MKT CAP: $364.66B
piotroski-score
7/9
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (BLLN VS. UNH)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | BLLN | UNH | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 68.30% | 88.57% | -20.27 | UNH | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 2.90% | 11.47% | -8.57 | UNH | /roic <GO> |
| EV/EBITDA & P/E Valuation | 95.0x | 16.4x | +78.55 | UNH | /valuation <GO> |
| Free Cash Flow Yield | 0.29% | 6.48% | -6.19 | UNH | /fcf-yield <GO> |
| Operating Margin | 5.30% | 4.82% | +0.48 | BLLN | /operating-margins <GO> |
| Net Profit Margin | 2.40% | 3.14% | -0.74 | UNH | /net-margins <GO> |
| Revenue Growth (YoY) | 100.00% | 6.46% | +93.54 | BLLN | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 2.28% | -2.28 | UNH | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 22.24 | 3.12 | +19.12 | BLLN | /balance-sheet <GO> |
| Piotroski F-Score Quality ACTIVE | 9/9 | 7/9 | +2.00 | BLLN | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 7.00% | 6.74% | +0.26 | UNH | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 59.5 | 56.0 | +3.43 | BLLN | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.02 | 0.33 | +0.69 | BLLN | /macro-sensitivity <GO> |
| Forward P/E Multiple | 140.0x | 17.1x | +122.91 | UNH | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $5.42B | $364.66B | -$359.24B | UNH | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | BLLN REV | UNH REV | BLLN GROSS % | UNH GROSS % | BLLN FCF | UNH FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $305.1M | $447.57B | 68.3% | 88.7% | $15.7M | $16.07B |
| FY 2024 | $152.6M | $400.28B | 53.0% | 88.3% | -$46.8M | $20.70B |
| FY 2023 | $71.7M | $371.62B | 44.0% | 89.6% | -$56.9M | $25.68B |
| FY 2022 | — | $324.16B | — | 89.6% | — | $23.40B |
| FY 2021 | — | $287.60B | — | 89.2% | — | $19.89B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
BLLN // BETA 1.02
UNH // BETA 0.33